Top 2009 projects
PATH focuses on moving global health solutions—technologies, tools, and interventions—along the pathway from innovation to impact. With more than 80 projects and hundreds of partners, we use creativity and collaboration to improve global health every day.
The project summary below shows how our projects address many of the world’s most urgent global heath needs. The “On the map” and “More milestones” sections of this report highlight many of our most significant accomplishments of the year.
The “innovation funding” icon identifies PATH projects that received flexible support, such as support from individual donors, at a critical phase of their development.
Emerging and epidemic diseases
PATH lessens the burden of epidemic diseases—including malaria, tuberculosis, and HIV/AIDS—as well as emerging threats such as pandemic influenza.
AIDS, Population, and Health Integrated Assistance II
This community-based project promotes healthy behaviors and increases the use of health services in Kenya’s Western Province.
PATH and our partners are improving the quality, availability, and use of services that prevent mother-to-child transmission of HIV in South Africa.
MACEPA supports sub-Saharan African countries in rapidly scaling up and sustaining the impact of malaria prevention and control efforts.
Technical Assistance Support Contract, Tuberculosis (TB) Sector
PATH provides short- and long-term technical assistance to countries with high TB burdens.
PATH brings appropriately designed, affordable, and innovative technologies to low-resource settings. Our interventions help to improve immunization, nutrition, diagnosis, child survival, and maternal and reproductive health.
Our “innovation engine” explores and tests new ideas for technology solutions to global health problems.
This project focuses on sterile, single-dose, needle-free syringes for administering vaccines.
This project seeks to bring household water treatment and storage products to the world’s poorest consumers.
HealthTech has focused on adapting, designing, developing, and advancing technology solutions since 1987.
This project explores approaches that protect vaccines from heat and freeze damage.
Maternal and child health
PATH improves the health of women and children by applying promising approaches to address the leading causes of maternal and child death. Our projects focus on safe birth and newborn care, nutrition, and the control of diarrheal disease.
IYCN works to improve nutrition during the critical time from pregnancy through the first two years of life.
POPPHI focused on prevention and early treatment of postpartum hemorrhage worldwide.
PATH and our many partners are reducing infant and maternal illness and death in India.
When blended with traditional rice, nutrient-rich Ultra Rice® meets the needs of low-resource, rice-consuming populations.
PATH works to prevent cervical cancer; advocate for services and supplies; address family-planning needs; prevent sexually transmitted infections, including HIV; expand options for abortion-related care; and encourage healthier behaviors.
In India, Peru, Uganda, and Vietnam, PATH is exploring the most effective vaccination strategies for human papillomavirus (HPV).
PATH is advancing low-cost molecular tests for the types of HPV that cause cervical cancer.
Vaccines and immunization
PATH closes gaps in access to lifesaving vaccines. Our projects accelerate vaccine research and development, expand access to new vaccines, and strengthen health systems.
This project seeks to develop new influenza vaccines for use in low-resource countries.
PATH and emerging-country vaccine manufacturers are developing safe, effective, and affordable rotavirus vaccines.
Children’s Vaccine Program
Our longest-running immunization program works to ensure that children receive the full benefits of new and underused vaccines.
PATH and our partners are advancing vaccines against the leading bacterial causes of diarrheal disease: enterotoxigenic Escherichia coli and Shigella.
This project helped countries control JE by determining disease burden, accelerating availability of an affordable vaccine, and assisting with vaccine introduction.
MVI works to accelerate development of malaria vaccines and to ensure their availability and accessibility in the developing world.
This partnership between PATH and the World Health Organization (WHO) works to eliminate epidemic meningitis in sub-Saharan Africa by focusing on the development, testing, and introduction of conjugate meningococcal vaccines.
This PATH–WHO partnership works to transform the way vaccines and other health products reach underserved populations.
PATH is advancing research and development of new pneumococcal vaccines for infants and children in the developing world.
PATH, WHO, and the US Centers for Disease Control and Prevention helped establish an evidence base for accelerated rotavirus vaccine introduction in the developing world.
The global reach of our partnerships
PATH has formal collaborations with nearly 700 partners around the world.
Collaboration across disciplines
PATH collaborates with a range of partners to build skills and bring the right experience to every project.
Sharing resources and knowledge
In addition to our technical support, PATH’s financial support helps to align our partners’ capacity with our global health priorities.